Pharmaceutical Advertisement: Therapeutic or Toxic?
Editor's Note: This is a series on the effect of pharmaceutical advertisements. See Part I and Part II to the series...
Snigdha is driven by a passion for improving patient lives by increasing access to quality and affordable medicine. After completing a master’s degree in clinical pharmacy, she worked for seven years in several
global roles within the pharmaceutical industry and developed in-depth understanding of chronic and critical care medicine. She enjoys writing about innovations in healthcare which have the potential to alter the current treatment landscape. She is currently pursuing a master’s degree in health policy and management from Columbia University and contemplates on policy interventions for complex healthcare scenarios to improve access to healthcare.
Editor's Note: This is a series on the effect of pharmaceutical advertisements. See Part I and Part II to the series...
- Exploring the effects of direct to consumer advertisements of pharmaceuticals - Part II: Direct to consumer pharmaceutical advertisement in...
Part I: Direct to consumer pharmaceutical advertisement in United States: History and regulatory landscape The one-minute advertisement which depicts a...
As a young clinical pharmacist and counselor, the frequency of prescriptions and counseling sessions for mental health patients was alarming....
Impakter informs you through the ESG news site and empowers your business CSRD compliance and ESG compliance with its Klimado SaaS ESG assessment tool marketplace that can be found on: www.klimado.com
Registered Office Address
Klimado GmbH
Niddastrasse 63,
60329, Frankfurt am Main, Germany
IMPAKTER is a Klimado GmbH website
Impakter is a publication that is identified by the following International Standard Serial Number (ISSN) is the following 2515-9569 (Printed) and 2515-9577 (online – Website).
Office Hours - Monday to Friday
9.30am - 5.00pm CEST
stories [at] impakter.com
© 2025 IMPAKTER. All rights reserved.